AdaptHealth Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
AdaptHealth wird ein jährliches Gewinn- und Umsatzwachstum von 94% bzw. 3.5% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 90.4% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 10.8% betragen.
Wichtige Informationen
94.0%
Wachstumsrate der Gewinne
90.4%
EPS-Wachstumsrate
| Healthcare Gewinnwachstum | 21.1% |
| Wachstumsrate der Einnahmen | 3.5% |
| Zukünftige Eigenkapitalrendite | 10.8% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 15 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
We Think AdaptHealth (NASDAQ:AHCO) Is Taking Some Risk With Its Debt
Nov 13
Returns On Capital Signal Tricky Times Ahead For AdaptHealth (NASDAQ:AHCO)
Oct 22AdaptHealth Corp.'s (NASDAQ:AHCO) Share Price Boosted 26% But Its Business Prospects Need A Lift Too
Sep 06Is There An Opportunity With AdaptHealth Corp.'s (NASDAQ:AHCO) 37% Undervaluation?
Jul 14AdaptHealth Corp.'s (NASDAQ:AHCO) Low P/S No Reason For Excitement
Jun 25AdaptHealth (NASDAQ:AHCO) Is Reinvesting At Lower Rates Of Return
Jun 04Here's Why AdaptHealth (NASDAQ:AHCO) Has A Meaningful Debt Burden
Apr 03Market Might Still Lack Some Conviction On AdaptHealth Corp. (NASDAQ:AHCO) Even After 50% Share Price Boost
Mar 07AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business
Feb 16Many Still Looking Away From AdaptHealth Corp. (NASDAQ:AHCO)
Jan 18AdaptHealth (NASDAQ:AHCO) Use Of Debt Could Be Considered Risky
Nov 15Returns On Capital At AdaptHealth (NASDAQ:AHCO) Paint A Concerning Picture
Oct 18Is It Too Late To Consider Buying AdaptHealth Corp. (NASDAQ:AHCO)?
Sep 27Here's What's Concerning About AdaptHealth's (NASDAQ:AHCO) Returns On Capital
Jul 19Here's Why AdaptHealth (NASDAQ:AHCO) Is Weighed Down By Its Debt Load
Jul 04Is Now The Time To Look At Buying AdaptHealth Corp. (NASDAQ:AHCO)?
Jun 16AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business
Apr 10Here's Why AdaptHealth (NASDAQ:AHCO) Is Weighed Down By Its Debt Load
Mar 22Why AdaptHealth Corp. (NASDAQ:AHCO) Could Be Worth Watching
Feb 23Investors Interested In AdaptHealth Corp.'s (NASDAQ:AHCO) Earnings
Jan 24AdaptHealth (NASDAQ:AHCO) Has A Somewhat Strained Balance Sheet
Dec 16We Ran A Stock Scan For Earnings Growth And AdaptHealth (NASDAQ:AHCO) Passed With Ease
Nov 28AdaptHealth named a Fresh Pick at Baird after investor day
Sep 19AdaptHealth: Operating Performance Stretching Up, Valuation Less So
Aug 30AdaptHealth Q2 2022 Earnings Preview
Aug 08AdaptHealth gains ahead of addition to S&P SmallCap 600
Aug 02Here's Why AdaptHealth (NASDAQ:AHCO) Has A Meaningful Debt Burden
Jun 27Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 3,521 | 151 | N/A | N/A | 6 |
| 12/31/2025 | 3,341 | 120 | 232 | 530 | 9 |
| 12/31/2024 | 3,233 | 75 | 176 | 476 | 8 |
| 9/30/2024 | 3,263 | -218 | 229 | 547 | N/A |
| 6/30/2024 | 3,261 | -690 | 166 | 501 | N/A |
| 3/31/2024 | 3,248 | -695 | 53 | 389 | N/A |
| 12/31/2023 | 3,200 | -679 | 143 | 481 | N/A |
| 9/30/2023 | 3,122 | -427 | 31 | 422 | N/A |
| 6/30/2023 | 3,075 | 42 | 22 | 431 | N/A |
| 3/31/2023 | 3,009 | 40 | 44 | 448 | N/A |
| 12/31/2022 | 2,971 | 63 | -18 | 374 | N/A |
| 9/30/2022 | 2,903 | 87 | 66 | 378 | N/A |
| 6/30/2022 | 2,800 | 125 | 20 | 298 | N/A |
| 3/31/2022 | 2,689 | 184 | 79 | 324 | N/A |
| 12/31/2021 | 2,465 | 142 | 72 | 276 | N/A |
| 9/30/2021 | 2,115 | 40 | 68 | 225 | N/A |
| 6/30/2021 | 1,746 | -64 | 124 | 232 | N/A |
| 3/31/2021 | 1,361 | -131 | 122 | 190 | N/A |
| 12/31/2020 | 1,071 | -162 | 156 | 196 | N/A |
| 9/30/2020 | 858 | -91 | 133 | 163 | N/A |
| 6/30/2020 | 710 | -44 | 124 | 145 | N/A |
| 3/31/2020 | 602 | -50 | 45 | 69 | N/A |
| 12/31/2019 | 530 | -21 | 39 | 60 | N/A |
| 9/30/2019 | 489 | -8 | 52 | 68 | N/A |
| 6/30/2019 | 454 | 8 | 57 | 72 | N/A |
| 3/31/2019 | 398 | 14 | 61 | 73 | N/A |
| 12/31/2018 | 345 | 23 | 58 | 68 | N/A |
| 12/31/2017 | 193 | 10 | N/A | 46 | N/A |
| 12/31/2016 | 174 | -4 | N/A | 30 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: AHCO wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (2.6%).
Ertrag vs. Markt: AHCO wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.
Hohe Wachstumserträge: AHCO wird voraussichtlich in den nächsten 3 Jahren rentabel werden.
Einnahmen vs. Markt: AHCODie Einnahmen des Unternehmens (3.5% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.9% pro Jahr).
Hohe Wachstumseinnahmen: AHCODie Einnahmen des Unternehmens (3.5% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: AHCODie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (10.8%).